Boston Scientific Corp (BSX)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 35,136,000 | 32,469,000 | 32,229,000 | 30,777,000 | 30,565,000 |
| Total stockholders’ equity | US$ in thousands | 19,282,000 | 17,573,000 | 16,623,000 | 15,327,000 | 13,877,000 |
| Financial leverage ratio | 1.82 | 1.85 | 1.94 | 2.01 | 2.20 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $35,136,000K ÷ $19,282,000K
= 1.82
The financial leverage ratio of Boston Scientific Corp. has been gradually decreasing over the past five years, reflecting a trend towards lower leverage levels. The ratio declined from 2.20 in 2019 to 1.82 in 2023. This indicates that the company has been reducing its reliance on debt to finance its operations and investments. A lower financial leverage ratio suggests a stronger financial position and less financial risk, as the company is using less debt relative to equity in its capital structure. It may also imply improved ability to meet debt obligations and withstand economic downturns. Overall, the decreasing trend in Boston Scientific Corp.'s financial leverage ratio is a positive indicator of its financial health and stability.
Peer comparison
Dec 31, 2023